Share on StockTwits

A number of stock research firms have changed their ratings and price targets for Udg Healthcare PLC (LON: UDG) during the last seven days:

  • Udg Healthcare PLC had its price target raised by analysts at Jefferies Group from GBX 385 ($6.48) to GBX 400 ($6.74). They now have a “buy” rating on the stock.
  • Udg Healthcare PLC had its price target raised by analysts at Investec from GBX 305 ($5.14) to GBX 360 ($6.06). They now have a “hold” rating on the stock.
  • Udg Healthcare PLC had its “buy” rating reaffirmed by analysts at Goodbody Stockbrokers Ltd.
  • Udg Healthcare PLC had its “outperform” rating reaffirmed by analysts at Davy Research.
  • Udg Healthcare PLC had its “buy” rating reaffirmed by analysts at N+1 Singer. They now have a GBX 410 ($6.91) price target on the stock.
  • Udg Healthcare PLC had its “buy” rating reaffirmed by analysts at N 1 Singer. They now have a GBX 410 ($6.91) price target on the stock.

Udg Healthcare PLC (LON:UDG) opened at 327.00 on Friday. Udg Healthcare PLC has a 52-week low of GBX 293.30 and a 52-week high of GBX 380.10. The stock has a 50-day moving average of GBX 356.6 and a 200-day moving average of GBX 341.1. The company’s market cap is £789.1 million.

UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including the United States, the United Kingdom, Ireland, Germany, the Netherlands and Belgium.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.